FirstGroup plc - Notification of Directors' Interests in Shares
Each Non-Executive Director of the Company (other than David Dunn who receives
all of his fees in cash and Audrey Baxter and Colin Hood who receive all of
their fees in the form of shares in the Company) has elected to receive 40% of
his fees in the form of shares in the Company. Arrangements have been made for
these shares to be purchased on their behalf in the market on a regular basis.
Purchases took place on 25 June 2009 in accordance with standing instructions
as follows:-
Director Ordinary Shares of 5 pence each
Martin Gilbert 1,665
Audrey Baxter 578
David Begg 390
Jim Forbes 459
Colin Hood 690
Tim O' Toole 390
John Sievwright 390
Martyn Williams 170
Shares were purchased at a price of 370 pence per share.
The revised total beneficial holdings of the directors following these
transactions are:-
Director Ordinary Shares of 5 pence each
Martin Gilbert 119,628
Audrey Baxter 15,410
David Begg 13,628
Jim Forbes 30,927
Colin Hood 1,225
Tim O' Toole 690
John Sievwright 36,313
Martyn Williams 4,633
25 June 2009
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.